T1	Premise 52 168	A 67-year-old woman diagnosed with an infiltrating ductal carcinoma of the breast and no family history of neoplasia
T2	Claim 273 316	Complete phenotypic study by flow cytometry
T3	Claim 321 356	Study of hormone receptors and HER2
T4	Claim 361 435	Study of hormone receptors, e-cadherin and study of first degree relatives
T5	Claim 440 493	Study of BRCA 1-2 and study of first-degree relatives
T6	Claim 520 582	The correct answer would be 2, HORMONE AND HER2 RECEPTOR STUDY
T7	Claim 590 655	positive HER2 receptors imply greater aggressiveness of the tumor
T8	Marker 584 589	since
T9	Marker 656 659	but
T10	Claim 660 756	treatment with trastuzumab and positive hormone receptors would imply the use of hormone therapy
R1	Support Ent1:T6 Ent2:T3	
R2	Support Ent1:T7 Ent2:T6	
T11	Claim 758 793	Answer 1 can be ruled out visu visu
R3	Attack Ent1:T11 Ent2:T2	
T12	Claim 795 836	while answers 3 and 4 should be ruled out
T13	Premise 844 901	being the first woman in the family with breast carcinoma
R5	Attack Ent1:T12 Ent2:T4	
R6	Attack Ent1:T12 Ent2:T5	
R7	Support Ent1:T10 Ent2:T6	
T14	Diagnostics 282 316	phenotypic study by flow cytometry
T15	Diagnostics 321 356	Study of hormone receptors and HER2
T16	Diagnostics 361 399	Study of hormone receptors, e-cadherin
T17	Diagnostics 404 435	study of first degree relatives
T18	Diagnostics 440 457	Study of BRCA 1-2
T19	Diagnostics 462 493	study of first-degree relatives
T20	Marker 837 842	since
T21	Marker 827 836	ruled out
T22	Claim 903 963	the study of the patient's relatives would not be obligatory
R4	Support Ent1:T13 Ent2:T22	
R8	Support Ent1:T22 Ent2:T12	
